In a First, FDA Approves Immunotherapy Combination for Advanced Melanoma October 1, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma October 30, 2015December 14, 2022 Matthew Tontonoz
FDA Approves First in a New Class of Immunotherapies October 27, 2015December 14, 2022 Matthew Tontonoz
First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval November 20, 2015December 14, 2022 Alexandra Mulvey
